1
|
Bridges C, Shenk MER, Martin K, Launhardt A. Cutaneous manifestations of childhood Eosinophilic Granulomatosis with Polyangiitis (cEGPA): A case-based review. Pediatr Dermatol 2020; 37:604-612. [PMID: 32212191 DOI: 10.1111/pde.14144] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
BACKGROUND/OBJECTIVES This study seeks to better define the clinical presentation and histopathology of cutaneous manifestations in childhood eosinophilic granulomatosis with polyangiitis (cEGPA). METHODS Case reports were collected from Ovid Medline Database and PubMed using keyword identifiers from 1946 to 2017. Adult patients ≥ 18 years and cases not diagnosed with EGPA by the author were excluded. Sixty-five case reports of cEGPA were initially identified. These were reviewed individually, and fifty cases were determined to meet the American College of Rheumatology criteria for EGPA. No case series examining the cutaneous morphology and histopathology were identified. Cutaneous morphology, lesion location, and cutaneous histopathology results were recorded. Results were analyzed using summary statistics. RESULTS Sixty-four percent (32/50) of cEGPA patients presented with cutaneous manifestations. Twenty-nine cases provided specific morphological descriptions and lesion location. Common manifestations included purpura (15/29), subcutaneous nodules (8/29), and a macular/papular/maculopapular rash (8/29). However, twelve different cutaneous morphologies were identified in this review. Lesions occurred most commonly on the extremities (26/29). Twenty-two cases reported corresponding cutaneous histopathology, which revealed extravascular eosinophils (15/22), vasculitis (13/22), and granulomas (5/22). Only one biopsy sample (1/22) had all three classical EGPA characteristics of granulomas, extravascular eosinophils, and vasculitis. CONCLUSION With nearly two-thirds of cEGPA patients presenting with cutaneous manifestation, this study highlights the importance of clinical recognition of this disease by dermatologists. While the varied morphology of skin lesions and rarity of this disease makes cEGPA a difficult diagnosis, prompt recognition and treatment will improve outcomes in this patient population.
Collapse
Affiliation(s)
- Catherine Bridges
- Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri
| | | | - Kari Martin
- Department of Dermatology, University of Missouri, Columbia, Missouri
| | | |
Collapse
|
2
|
Fina A, Dubus JC, Tran A, Derelle J, Reix P, Fayon M, Couderc L, Donnou MD, Pagnier A, Blanchon S, Faure N, Mely L, Albertini M, de Blic J, Giovannini-Chami L. Eosinophilic granulomatosis with polyangiitis in children: Data from the French RespiRare® cohort. Pediatr Pulmonol 2018; 53:1640-1650. [PMID: 29943913 DOI: 10.1002/ppul.24089] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/13/2018] [Accepted: 06/10/2018] [Indexed: 01/30/2023]
Abstract
OBJECTIVES To describe the characteristics of pediatric cases of eosinophilic granulomatosis with polyangiitis (EGPA), a systemic necrotizing vasculitis rarely diagnosed in children, retrieved from the French Reference Center for rare pediatric lung diseases and compared with adult cases included in the French Vasculitis Study Group cohort. METHODS We collected information on pediatric EGPA disease presentation, management, and outcome. Cases met the Lanham criteria and/or American College of Rheumatology classification criteria. RESULTS Fourteen cases of pediatric EGPA were included, from 1980 to 2012, with a median follow-up of 58.5 months. Median age at diagnosis was 12.3 years. All cases had respiratory involvement. The organ systems most frequently involved were the upper airway (85%), skin (71%), digestive tract (64%), and heart (57%). Neurological and renal involvement were rare. Four of the fourteen children were positive for ANCA (30.7%). During follow-up, three children required intensive care and one child died. The relapse rate was 64%. In comparison with an adult cohort, we found more ENT, heart, and digestive-tract involvement, and fewer neurological manifestations. In children, the delay between asthma onset and diagnosis was shorter, and biopsies showed fewer features of vasculitis. CONCLUSION This French cohort is the biggest pediatric EGPA series described to date, with a long follow-up period. The findings confirm that pediatric EGPA has specific clinical, radiological, and histological characteristics that differ from adult EGPA. Development of systemic symptoms, and consequently diagnosis, occur with a shorter delay in children, mainly during the eosinophilic phase and leading to a specific presentation.
Collapse
Affiliation(s)
- Agnès Fina
- Pediatric Pulmonology and Allergology Department, Hôpitaux pédiatriques de Nice CHU-Lenval, Nice, France
| | - Jean-Christophe Dubus
- Pediatric Pulmonology Department, APHM, Timone Enfant de Marseille, Marseille, France
| | - Antoine Tran
- Pediatric Pulmonology and Allergology Department, Hôpitaux pédiatriques de Nice CHU-Lenval, Nice, France
| | - Jocelyne Derelle
- Pediatric Pulmonology Department, Hôpital de Brabois, CHU de Nancy, Nancy, France
| | - Philippe Reix
- Pediatric Pulmonology Department and Pediatric CRCM, Hôpital Femme Mère Enfant, Hospices civils de Lyon, Bron, France.,UMR 5558 (EMET), CNRS, LBBE, Université de Lyon, Villeurbanne, France
| | - Michael Fayon
- Pediatric Pulmonology Department, Hôpital Pellegrin Enfants, Bordeaux, France
| | - Laure Couderc
- Pediatric Pulmonology Department, CHU Hôpital Charles-Nicolle, Rouen, France
| | | | - Anne Pagnier
- Pediatric Hematology and Oncology Department, CHRU de Grenoble, Grenoble, France
| | - Sylvain Blanchon
- Pediatric Pulmonology and Allergology Department, Hôpital des enfants, CHU de Toulouse, Toulouse, France
| | - Nathalie Faure
- Pediatric Pulmonology Department, Hôpital Clocheville, CHRU de Tours, Tours, France
| | - Laurent Mely
- Pediatric Pulmonology Department, Hôpital Renée Sabran, Giens, France
| | - Marc Albertini
- Pediatric Pulmonology and Allergology Department, Hôpitaux pédiatriques de Nice CHU-Lenval, Nice, France.,Université Côte d'Azur, Nice, France
| | - Jacques de Blic
- Pediatric Pulmonology and Allergology Department, APHP, Hôpital Necker, Paris, France
| | - Lisa Giovannini-Chami
- Pediatric Pulmonology and Allergology Department, Hôpitaux pédiatriques de Nice CHU-Lenval, Nice, France.,Université Côte d'Azur, Nice, France
| |
Collapse
|
5
|
Razenberg FGEM, Heynens JWCM, Jan de Vries G, Duijts L, de Jongste JC, de Blic J, Rosias PPR. Clinical presentation of Churg-Strauss syndrome in children: A 12-year-old-boy with ANCA-negative Churg-Strauss syndrome. Respir Med Case Rep 2012; 7:4-7. [PMID: 26029598 PMCID: PMC3920348 DOI: 10.1016/j.rmcr.2012.09.004] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2012] [Revised: 09/07/2012] [Accepted: 09/18/2012] [Indexed: 11/18/2022] Open
Abstract
Churg–Strauss syndrome is an uncommon multisystem disorder characterized by asthma, eosinophilia and vasculitis. We report on a 12-year-old boy with asthma and deterioration of his general condition, who was eventually diagnosed with an ANCA-negative Churg–Strauss syndrome. The propositus included, 50 cases of childhood Churg–Strauss syndrome have been reported. The patient characteristics and clinical characteristics of these children are summarized. The respiratory tract is most frequently involved with pulmonary infiltrates, asthma and sinusitis. Early recognition of childhood Churg–Strauss syndrome is important as delayed diagnosis can lead to severe organ involvement, and possible fatal outcome.
Collapse
Affiliation(s)
- Femke G E M Razenberg
- Department of Pediatrics, Orbis Medical Center, PO Box 5500, 6130 MB Sittard, The Netherlands
| | - Jan W C M Heynens
- Department of Pediatrics, Orbis Medical Center, PO Box 5500, 6130 MB Sittard, The Netherlands
| | | | - Liesbeth Duijts
- Department of Pediatrics, Division of Respiratory Medicine, Erasmus Medical Center, Rotterdam, The Netherlands ; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands
| | - Johan C de Jongste
- Department of Pediatrics, Division of Respiratory Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
| | - Jacques de Blic
- Université Paris Descartes, Assistance Publique des Hôpitaux de Paris, Service de Pneumologie et Allergologie Pédiatriques, Hôpital Necker Enfants Malades, Paris, France
| | - Philippe P R Rosias
- Department of Pediatrics, Orbis Medical Center, PO Box 5500, 6130 MB Sittard, The Netherlands
| |
Collapse
|